Dificid

Merck Sharp & Dohme LLC🇺🇸 United States

FDA Page

Effective Date: Nov 20, 2023
Approval ID: dd966338-c820-4270-b704-09ef75fa3ceb
Products: 2 registered
Version: 19

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DIFICID safely and effectively. See full prescribing information for DIFICID. DIFICID (fidaxomicin) tablets, for oral use DIFICID (fidaxomicin) for oral suspension Initial U.S. Approval: 2011

Quick Stats

Total Products2

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.